Vertex Pharmaceuticals Inc. buy Wolfe Research
Start price
15.02.24
/
50%
€393.55
Target price
15.02.25
€478.13
Performance (%)
11.82%
End price
16.02.25
€440.05
Summary
This prediction ended on 16.02.25 with a price of €440.05. The BUY prediction by Wolfe_Research finished with a performance of 11.82%. Wolfe_Research has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 4.505% | 4.505% | -8.627% |
| iShares Core DAX® | -1.338% | -5.619% | 3.378% |
| iShares Nasdaq 100 | -1.067% | 2.598% | 19.132% |
| iShares Nikkei 225® | -1.991% | -6.512% | 27.854% |
| iShares S&P 500 | -1.316% | 0.905% | 14.189% |
Comments by Wolfe_Research for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $515.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Wolfe_Research for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€389.95
06.01.26
06.01.26
€467.39
06.01.27
06.01.27
5.77%
10:43
10:43
